Top Story

Statin use in HCV patients may lower risk of death, decompensation

April 25, 2015

VIENNA — Statin use in patients with hepatitis C virus and compensated cirrhosis seems to offer a protective effect against death and decompensation, according to a study presented at the 2015 International Liver Congress.

“In compensated HCV cirrhosis, statin users have a significantly lower incidence of decompensation and better overall survival compared to statin non-users,” Arpan Mohanty, MD, from Yale School of Medicine, New Haven, Conn., said during her presentation. “Risk of decompensation and death was reduced by over 40%.”

Meeting News Coverage

Harvoni induces high response rates in genotype 4, 5 HCV

April 25, 2015
VIENNA — Patients with genotype 4 and 5 hepatitis C virus benefitted from treatment with Harvoni, according to findings presented at the 2015 International Liver…
VIDEO: C-SURFER: Patients with kidney disease, HCV achieve high rates of SVR Meeting News CoverageVideo

VIDEO: C-SURFER: Patients with kidney disease, HCV achieve high rates of SVR

April 25, 2015
VIENNA — Howard Monsour Jr., MD, chief of hepatology, Houston Methodist Hospital, Texas, discussed results of the C-SURFER trial, where 99% of patients with…
Meeting News Coverage

C-SWIFT: 8 weeks of therapy may be possible with grazoprevir/elbasvir

April 25, 2015
VIENNA — Patients with cirrhosis as well as genotype 1 and genotype 3 HCV responded favorably to 8 weeks of treatment with a novel grazoprevir and elbasvir-based…
Chikungunya common among US volunteers in Dominican Republic Meeting News Coverage

Chikungunya common among US volunteers in Dominican Republic

April 24, 2015
Infection with chikungunya was common among a group of United States volunteers working in the Dominican Republic during a large outbreak there, according to recent…
More News Headlines »
CME
HCV VOICE

HCV VOICE II: Optimizing Virological Outcomes with Integrated HCV Education

This activity is supported by an educational grant from Janssen Therapeutics, Division of Janssen Products, LP.

Chronic hepatitis C virus (HCV) infection is a leading cause of cirrhosis, end-stage liver disease, hepatocellular…
More »
Meeting News Coverage Video
VIDEO: Effectiveness of inactivated vs. live flu vaccine currently unclear

VIDEO: Effectiveness of inactivated vs. live flu vaccine currently unclear

April 24, 2015
BETHESDA, Md. — Richard K. Zimmerman, MD, of the University of Pittsburgh, explains the results of his study…
More »
CME
Management of Pediatric Conjunctivitis and Otitis/Conjunctivitis Syndrome

Management of Pediatric Conjunctivitis and Otitis/Conjunctivitis Syndrome

This activity is supported by an educational grant from Alcon Research, LTD.

More »
morganatic-roan
morganatic-roan